S. Dengl

发表

Structure of eukaryotic RNA polymerases.

P. Cramer, E. Lehmann, H. Kettenberger, 2008, Annual review of biophysics.

Structural basis of transcription: mismatch-specific fidelity mechanisms and paused RNA polymerase II with frayed RNA.

P. Cramer, E. Lehmann, D. Vassylyev, 2009, Molecular cell.

in Vitro Terminate RNA Polymerase II Nuclease Rat 1 Is Insufficient to Torpedo Epigenetics : Transcription , Chromatin , and

P. Cramer, S. Dengl, 2009 .

PK modulation of haptenylated peptides via non-covalent antibody complexation.

U. Brinkmann, I. Thorey, K. Stubenrauch, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Structure and requirement of the Spt6 SH2 domain and an in vitro system to test the "torpedo model" of transcription termination

Stefan Dengl, S. Dengl, 2009 .

Torpedo Nuclease Rat1 Is Insufficient to Terminate RNA Polymerase II in Vitro*

P. Cramer, S. Dengl, 2009, The Journal of Biological Chemistry.

A Tandem SH2 Domain in Transcription Elongation Factor Spt6 Binds the Phosphorylated RNA Polymerase II C-terminal Repeat Domain (CTD)*

P. Cramer, A. Mayer, S. Dengl, 2010, The Journal of Biological Chemistry.

Format chain exchange (FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matrices

Andreas Kuglstatter, Klaus Mayer, Stefan Dengl, 2020, Nature Communications.

Structure and in vivo requirement of the yeast Spt6 SH2 domain.

Patrick Cramer, Stefan Dengl, Andreas Mayer, 2009, Journal of molecular biology.

Allosteric antibody inhibition of human hepsin protease.

P. Cramer, G. Georges, S. Hansen, 2012, The Biochemical journal.

Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies

J. Buchner, S. Dengl, J. Stracke, 2016, mAbs.

Engineered hapten‐binding antibody derivatives for modulation of pharmacokinetic properties of small molecules and targeted payload delivery

U. Brinkmann, S. Dengl, C. Sustmann, 2016, Immunological reviews.

Hapten-directed spontaneous disulfide shuffling: a universal technology for site-directed covalent coupling of payloads to antibodies

U. Brinkmann, I. Thorey, K. Stubenrauch, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The Contorsbody, an antibody format for agonism: Design, structure, and function

U. Brinkmann, H. Stahlberg, M. Lauer, 2020, Computational and structural biotechnology journal.

Aggregation and Chemical Modification of Monoclonal Antibodies under Upstream Processing Conditions

Oliver Popp, Florian Lipsmeier, Kurt Lang, 2013, Pharmaceutical Research.

Abstract 2270: RG7769 (PD1-TIM3), a novel heterodimeric avidity-driven T cell specific PD-1/TIM-3 bispecific antibody lacking Fc-mediated effector functions for dual checkpoint inhibition to reactivate dysfunctional T cells

C. Klein, A. Bujotzek, G. Georges, 2020 .

Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin

S. Dengl, Simon Hauri, A. Caruso, 2020, Pharmaceutics.

Interplay between reversible phosphorylation and irreversible ADP-ribosylation of eukaryotic translation elongation factor 2

I. Pastan, U. Brinkmann, S. Dengl, 2018, Biological chemistry.

Aggregation and Chemical Modification of Monoclonal Antibodies under Upstream Processing Conditions

F. Hesse, F. Lipsmeier, S. Dengl, 2013, Pharmaceutical Research.

Structural basis of transcription: mismatch-specific fidelity mechanisms and paused RNA polymerase II with frayed RNA.

P. Cramer, E. Lehmann, D. Vassylyev, 2009, Molecular cell.

Allosteric antibody inhibition of human hepsin protease.

P. Cramer, G. Georges, S. Hansen, 2012, The Biochemical journal.

PK modulation of haptenylated peptides via non-covalent antibody complexation.

U. Brinkmann, I. Thorey, K. Stubenrauch, 2013, Journal of Controlled Release.